These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17384500)

  • 1. Long-term erythropoietin therapy does not affect metalloproteinases and their inhibitor levels, oxidative stress and inflammation in hemodialyzed patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Am J Nephrol; 2007; 27(3):221-5. PubMed ID: 17384500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating beta-chemokines and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system in hemodialyzed patients--role of oxidative stress.
    Pawlak K; Pawlak D; Mysliwiec M
    Cytokine; 2005 Jul; 31(1):18-24. PubMed ID: 15896974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic inflammation, oxidative stress and effects of erythropoetin in end-stage renal disease patients].
    Lazarević T; Stojimirović B; Poskurica M; Lazarević M; Mitrović N; Stolić R
    Med Pregl; 2007; 60 Suppl 2():109-13. PubMed ID: 18928173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term erythropoietin therapy does not affect endothelial markers, coagulation activation and oxidative stress in haemodialyzed patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2007; 120(6):797-803. PubMed ID: 17391740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term erythropoietin therapy decreases CC-chemokine levels and intima-media thickness in hemodialyzed patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Am J Nephrol; 2006; 26(5):497-502. PubMed ID: 17119331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
    Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
    Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2008; 121(6):787-91. PubMed ID: 17869326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
    Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
    Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
    Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR
    Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and ferritin levels in haemodialysis patients.
    Senol E; Ersoy A; Erdinc S; Sarandol E; Yurtkuran M
    Nephrol Dial Transplant; 2008 Feb; 23(2):665-72. PubMed ID: 18039638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of oxidative stress and inflammation on rHuEPO requirements of hemodialysis patients with CRP values "in normal range".
    Tutal E; Sezer S; Bilgic A; Aldemir D; Turkoglu S; Demirel O; Ozdemir N; Haberal M
    Transplant Proc; 2007 Dec; 39(10):3035-40. PubMed ID: 18089316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Matrix metalloproteinases and their tissue inhibitors in children and young adults on chronic hemodialysis--preliminary results].
    Musiał K; Makulska I; Zwolńska D
    Pol Merkur Lekarski; 2009 Apr; 26(154):290-3. PubMed ID: 19580190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
    Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
    Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3.
    Stefanovic V; Mitić-Zlatkovic M; Radivojevic J; Vlahovic P
    Ren Fail; 2005; 27(3):283-8. PubMed ID: 15957544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of erythropoietin therapy and selenium supplementation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis.
    Adamowicz A; Trafikowska U; Trafikowska A; Zachara B; Manitius J
    Med Sci Monit; 2002 Mar; 8(3):CR202-5. PubMed ID: 11887037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment.
    Stasko J; Galajda P; Ivanková J; Hollý P; Rozborilová E; Kubisz P
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):410-5. PubMed ID: 17911193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation between serum leptin levels, blood parameters and erythropoietin levels in hemodialyzed patients].
    Haluzík M; Marková M; Sulková S; Haluzíková D; Svobodová J; Bednárová V; Jiskra J
    Cas Lek Cesk; 2000 Nov; 139(23):731-4. PubMed ID: 11191744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive oxygen metabolites: a link between oxidative stress and inflammation in patients on hemodialysis.
    Samouilidou E; Grapsa E; Karpouza A; Lagouranis A
    Blood Purif; 2007; 25(2):175-8. PubMed ID: 17215574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-type plasminogen activator and metalloproteinase-2 are independently related to the carotid atherosclerosis in haemodialysis patients.
    Pawlak K; Pawlak D; Myśliwiec M
    Thromb Res; 2008; 121(4):543-8. PubMed ID: 17706748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recombinant human erythropoietin (rh-EPO) in chronic, dialysis-dependent renal failure: effects on macro- and microcirculation and hematologic parameters].
    Köhler M; Mörsdorf S; Jung F; Braun B; Waldhausen P; Pindur G; Weber U; Bosslet R; Bambauer R; Jutzler GA
    Beitr Infusionsther; 1990; 26():89-95. PubMed ID: 1703909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.